Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-gq7q9 Total loading time: 0 Render date: 2024-07-19T05:33:37.811Z Has data issue: false hasContentIssue false

Case 30 - More than Mononucleosis

Published online by Cambridge University Press:  01 March 2019

Tom Solomon
Affiliation:
University of Liverpool
Benedict D. Michael
Affiliation:
Institute of Infection & Global Health, University of Liverpool
Alastair Miller
Affiliation:
Tropical & Infectious Disease Unit, Royal Liverpool Hospital
Rachel Kneen
Affiliation:
Alder Hey Children’s Hospital, Liverpool
Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Dexter, LJ. The pathogenesis of primary, latent and reactivated Epstein–Barr virus infections: an update on clinically relevant interactions between Epstein–Barr virus and the human immune response. Rev Med Microbiol 2011;22:4854.CrossRefGoogle Scholar
Okano, . Acute or chronic life-threatening diseases associated with Epstein–Barr virus infection. Am J Med Sci 2012;343:483–9.CrossRefGoogle ScholarPubMed
Rouphael, NG, Talati, NJ Vaughan, C, et al. Infections associated with haemophagocytic syndrome. Lancet Infect Dis 2007;7:814–22.CrossRefGoogle ScholarPubMed
Lee, J, Chung, I, Shin, D, et al. Hemorrhagic fever with renal syndrome presenting with hemophagocytic lymphohistiocytosis. Emerg Infect Dis. 2002;8:209–10.CrossRefGoogle ScholarPubMed
Zhang, K, Filipovich, AH, Johnson, J, Marsh, RA, Villanueva, J, editors. Hemophagocytic Lymphohistiocytosis, Familial. Seattle, WA: University of Washington; 2006.Google ScholarPubMed
Henter, J, Horne, A, Aricó, M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124–31.Google Scholar
Imashuku, S, Teramura, T, Tauchi, H, et al. Longitudinal follow-up of patients with Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis. Haematologica 2004;89:183–8.Google Scholar
Berry, PA, Bernal, W, Pagliuca, A, et al. Multiple organ failure and severe bone marrow dysfunction in two 18 year-old Caucasian patients: Epstein–Barr virus and the haemophagocytic syndrome. Anaesthesia 2008;63:1249–54.Google Scholar
Torti, L, Larocca, LM, Massini, G, et al. Epstein–Barr Virus (EBV)-associated haemophagocytic syndrome. Mediterr J Hematol Infect Dis 2012;4:e201.CrossRefGoogle ScholarPubMed
Imashuku, S, Kuriyama, K, Teramura, T, et al. Requirement for etoposide in the treatment of Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 2001;19:2665–73.CrossRefGoogle ScholarPubMed
Ishii, E, Ohga, S, Imashuku, S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 2007;86:5865.CrossRefGoogle ScholarPubMed
Canna, SW, Behrens, EM. Not all hemophagocytes are created equally: appreciating the heterogeneity of the hemophagocytic syndromes. Curr Opin Rheumatol 2012;24:113–18.CrossRefGoogle ScholarPubMed
Balamuth, NJ, Nichols, KE, Paessler, M, Teachey, DT. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis. J Pediatr Haem Oncol 2007;29:569–73.Google ScholarPubMed
Darteyre, S, Ludwig, C, Jeziorski, E, Schved, J-F, Rodière, M. Syndrome d’activation macrophagique et infection à virus d’Epstein–Barr chez l’enfant. Méd Malad Infect 2010; 40:1826.CrossRefGoogle Scholar
Janka, G, Imashuku, S, Elinder, G, Schneider, M, Henter, JI. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12:435–44.Google Scholar
Beutel, K, Gross-Wieltsch, U, Wiesel, T, et al. Infection of T lymphocytes in Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. Pediatr Blood Cancer 2009;53:184–90.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×